Atlas Trials

Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress

Clinical trial NCT06026163 · RECRUITING

Trial details

NCT number
NCT06026163
Sponsor
Ministry of Health, Saudi Arabia
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
PrematurityRespiratory DiseaseVentilator Lung; Newborn
Start date
2023-10-12
Primary completion
2027-10-30
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.